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Fig. 2
Kaplan-Meier plots showing probability of overall survival in GC patients stratified by KRAS gene activation status. a KaplanMeier survival analysis showed no difference in survival when patients were stratified by KRAS mutation status. b Kaplan-Meier survival analysis showed no difference in survival when patients were stratified by KRAS amplification status
